Doberstein Stephen K 4
4 · NEKTAR THERAPEUTICS · Filed Sep 9, 2019
Insider Transaction Report
Form 4
Doberstein Stephen K
Chief Scientific Officer
Transactions
- Purchase
Common Stock
2019-09-05$17.28/sh+15,000$259,200→ 107,668 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $17.18 to $17.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.